PK-AMIO study is a population pharmacokinetic study of Amiodarone in children in order to : * study the pharmacokinetic parameters (Pop PK) of Amiodarone in children; * identify covariates explaining the variability of these pharmacokinetic parameters; * study the relationship between the concentration, the efficacy of treatment and its tolerance to optimize the use of Amiodarone in pediatrics. Indeed, there is no consensus on the optimal oral dosage in children. Few pharmacokinetic studies have been performed with only a small number of patients per study. Our study will include 70 children aged 0 to 18 years old.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Maximal Concentration (Cmax) of amiodarone
Timeframe: Hour 0 to Hour 24
Area under the plasma concentration versus time curve (AUC) of amiodarone
Timeframe: Hour 0 to Hour 24
Clearance of amiodarone
Timeframe: Hour 0 to Hour 24
Volume of distribution of amiodarone
Timeframe: Hour 0 to Hour 24
Half time of amiodarone
Timeframe: Hour 0 to Hour 24